EN
HI
Oxygenta Pharmaceutical Chart
Oxygenta Pharmaceutical Share Key Metrics
Volume
6358.00
Market Cap
182.92 CR
LTQ@LTP
130@49.35
ATP
49.44
Var Margin
26.96 %
Circuit Range
39.57-59.35
Delivery %
76.99 %
Value
3.14 L
ASM/GSM
No
Market Lot
1
Summary
Oxygenta Pharmaceutical share price is ₹49.35 as of 3 Jun, 2026. The stock Oxygenta Pharmaceutical intraday movement has stayed between ₹48.30 and ₹50.79, while on a 52-week basis,Oxygenta Pharmaceutical price 52 week high is ₹133.50 & its 52 week low is ₹45.30.
In terms of trading activity, Oxygenta Pharmaceutical has recorded a volume of 6358 shares, The Oxygenta Pharmaceutical has a market cap of ₹36983500 CR. The stock’s Average Traded Price (ATP) stands at ₹49.44, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 130 @ ₹49.35.
Oxygenta Pharmaceutical operates within a circuit range of ₹39.57 – ₹59.35, with a Value of ₹3.14 L. The Delivery Percentage for the day is 76.99%. Additionally, Oxygenta Pharmaceutical currently falls under the No framework, and trades with a market lot size of 1.
Oxygenta Pharmaceutical Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
69.53
Sector P/B
2.99
Sec. Div. Yield
0.55
Oxygenta Pharmaceutical Resistance and Support
Pivot 50.8
Resistance
First Resistance
52.6
Second Resistance
55.75
Third Resistance
57.55
Support
First Support
47.65
Second Support
45.85
Third Support
42.7
Oxygenta Pharmaceutical Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-23 | Audited Results |
| 2026-02-04 | Quarterly Results |
| 2025-11-07 | Quarterly Results |
| 2025-08-14 | Quarterly Results |
| 2025-05-30 | Audited Results |
| 2025-02-14 | Quarterly Results |
Oxygenta Pharmaceutical News
Oxygenta Pharmaceutical Ltd - 524636 - Announcement under Regulation 30 (LODR)-Change in Management
Oxygenta Pharma appointed Mr. Amireddy Venkatesu Reddy as Executive Director for a 3-year term, and Mr. Janardhana Reddy Yeddula as an Independent Director for a 5-year term. Both appointments are effective May 23, 2026, and await shareholder approval.
May 23 2026 17:47:21
Oxygenta Pharmaceutical Ltd - 524636 - Board Meeting Intimation for The Meeting To Be Held On Saturday, 23Rd May, 2026.
Oxygenta Pharmaceutical's board will convene on May 23, 2026, to review and approve the audited financial results for the quarter and financial year ended March 31, 2026. The meeting will also consider the audit report for FY26.
May 19 2026 12:13:23
Oxygenta Pharmaceutical Management
| Name | Position |
|---|---|
| Balasubba Reddy Mamilla | Whole Time Director |
| Chandra Mouliswar Reddy Gangavaram | Whole Time Director |
Oxygenta Pharmaceutical Similar Stocks
Oxygenta Pharmaceutical FAQs
The Buying Price of Oxygenta Pharmaceutical share is 49.35 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Oxygenta Pharmaceutical stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Oxygenta Pharmaceutical, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Oxygenta Pharmaceutical shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Oxygenta Pharmaceutical shares is 0. Useful to assess the stock's value relative to its book value.
To assess Oxygenta Pharmaceutical’s valuation compare Sector P/E, P/B which are 69.53 & 2.99 with sector averages, along with growth rates and financial metrics.
The Market Cap of Oxygenta Pharmaceutical is 182.92 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Oxygenta Pharmaceutical share price is 133.50 & 45.30. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Oxygenta Pharmaceutical belongs to the Healthcare sector.
